Literature DB >> 10396254

Artificial neural networks: a potential role in osteoporosis.

S A Rae1, W J Wang, D Partridge.   

Abstract

Artificial neural networks are computer software systems that recognize patterns in complex data sets. A recent development in neural computing, multiversion systems (MVS), has led to enhanced analytical power, and this was harnessed to demonstrate the value of risk factors in predicting the result of osteoporosis investigations by quantitative ultrasound. 274 women were screened in an open-access osteoporosis service. A conventional risk factor questionnaire was completed for each patient by the osteoporosis specialist nurse. An MVS was trained on 180 randomly selected data sets and tested on the remaining 94. The results were compared with those from logistic regression analysis in predictive power, both from the selected 20-item questionnaire and for a limited 5-item questionnaire comprising age, height, height loss, weight and years since the menopause. The MVS approach predicted the T-score categorization of the patients from the 20-item questionnaire with 83.0% accuracy, whereas logistic regression yielded an accuracy of only 72.8% (P = 0.04). From the 5-item database the MVS yielded a best prediction accuracy of 73.1%, whereas the logistic regression prediction accuracy was 60% (P = 0.04). These results suggest that 20 risk factors can be used by an MVS to predict the outcome of osteoporosis investigations with a power that outperforms conventional statistical methods. Use of this system may improve the selection of patients for osteoporosis investigations, since even with only 5 risk factors the system performs nearly as well as that based on the full 20 factors.

Entities:  

Mesh:

Year:  1999        PMID: 10396254      PMCID: PMC1297100          DOI: 10.1177/014107689909200305

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  7 in total

1.  Engineering multiversion neural-net systems.

Authors:  D Partridge; W B Yates
Journal:  Neural Comput       Date:  1996-05-15       Impact factor: 2.026

2.  An artificial neural network system for diagnosis of acute myocardial infarction (AMI) in the accident and emergency department: evaluation and comparison with serum myoglobin measurements.

Authors:  R L Kennedy; R F Harrison; A M Burton; H S Fraser; W G Hamer; D MacArthur; R McAllum; D J Steedman
Journal:  Comput Methods Programs Biomed       Date:  1997-02       Impact factor: 5.428

3.  Introduction to neural networks.

Authors:  S S Cross; R F Harrison; R L Kennedy
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

Review 4.  Artificial neural networks in pathology and medical laboratories.

Authors:  R Dybowski; V Gant
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

5.  Assessment of the risk of post-menopausal osteoporosis using clinical factors.

Authors:  C Ribot; J M Pouilles; M Bonneu; F Tremollieres
Journal:  Clin Endocrinol (Oxf)       Date:  1992-03       Impact factor: 3.478

6.  Use of an artificial neural network for the diagnosis of myocardial infarction.

Authors:  W G Baxt
Journal:  Ann Intern Med       Date:  1991-12-01       Impact factor: 25.391

7.  Screening for vertebral osteoporosis using individual risk factors. The Multicentre Vertebral Fracture Study Group.

Authors:  C Cooper; S Shah; D J Hand; J Adams; J Compston; M Davie; A Woolf
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

  7 in total
  2 in total

1.  Artificial neural networks in prediction of bone density among post-menopausal women.

Authors:  M Sadatsafavi; A Moayyeri; A Soltani; B Larijani; M Nouraie; S Akhondzadeh
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

2.  Predictive Behavior of a Computational Foot/Ankle Model through Artificial Neural Networks.

Authors:  Ruchi D Chande; Rosalyn Hobson Hargraves; Norma Ortiz-Robinson; Jennifer S Wayne
Journal:  Comput Math Methods Med       Date:  2017-01-30       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.